These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37205527)

  • 1.
    Goudy OJ; Nallathambi A; Kinjo T; Randolph N; Kuhlman B
    bioRxiv; 2023 May; ():. PubMed ID: 37205527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico evolution of autoinhibitory domains for a PD-L1 antagonist using deep learning models.
    Goudy OJ; Nallathambi A; Kinjo T; Randolph NZ; Kuhlman B
    Proc Natl Acad Sci U S A; 2023 Dec; 120(49):e2307371120. PubMed ID: 38032933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving de novo protein binder design with deep learning.
    Bennett NR; Coventry B; Goreshnik I; Huang B; Allen A; Vafeados D; Peng YP; Dauparas J; Baek M; Stewart L; DiMaio F; De Munck S; Savvides SN; Baker D
    Nat Commun; 2023 May; 14(1):2625. PubMed ID: 37149653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ProteinMPNN Recovers Complex Sequence Properties of Transmembrane β-barrels.
    Dolorfino M; Samanta R; Vorobieva A
    bioRxiv; 2024 Feb; ():. PubMed ID: 38352434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of High Affinity Binders to Convex Protein Target Sites.
    Yang W; Hicks DR; Ghosh A; Schwartze TA; Conventry B; Goreshnik I; Allen A; Halabiya SF; Kim CJ; Hinck CS; Lee DS; Bera AK; Li Z; Wang Y; Schlichthaerle T; Cao L; Huang B; Garrett S; Gerben SR; Rettie S; Heine P; Murray A; Edman N; Carter L; Stewart L; Almo S; Hinck AP; Baker D
    bioRxiv; 2024 May; ():. PubMed ID: 38746206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hallucinating structure-conditioned antibody libraries for target-specific binders.
    Mahajan SP; Ruffolo JA; Frick R; Gray JJ
    Front Immunol; 2022; 13():999034. PubMed ID: 36341416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constrained Combinatorial Libraries of Gp2 Proteins Enhance Discovery of PD-L1 Binders.
    Kruziki MA; Sarma V; Hackel BJ
    ACS Comb Sci; 2018 Jul; 20(7):423-435. PubMed ID: 29799714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of a protease-activated PD-L1 inhibitor.
    Goudy OJ; Peng A; Tripathy A; Kuhlman B
    Protein Sci; 2023 Mar; 32(3):e4578. PubMed ID: 36705186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Robust deep learning-based protein sequence design using ProteinMPNN.
    Dauparas J; Anishchenko I; Bennett N; Bai H; Ragotte RJ; Milles LF; Wicky BIM; Courbet A; de Haas RJ; Bethel N; Leung PJY; Huddy TF; Pellock S; Tischer D; Chan F; Koepnick B; Nguyen H; Kang A; Sankaran B; Bera AK; King NP; Baker D
    Science; 2022 Oct; 378(6615):49-56. PubMed ID: 36108050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. De novo design of protein interactions with learned surface fingerprints.
    Gainza P; Wehrle S; Van Hall-Beauvais A; Marchand A; Scheck A; Harteveld Z; Buckley S; Ni D; Tan S; Sverrisson F; Goverde C; Turelli P; Raclot C; Teslenko A; Pacesa M; Rosset S; Georgeon S; Marsden J; Petruzzella A; Liu K; Xu Z; Chai Y; Han P; Gao GF; Oricchio E; Fierz B; Trono D; Stahlberg H; Bronstein M; Correia BE
    Nature; 2023 May; 617(7959):176-184. PubMed ID: 37100904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the Potential of Structure-Based Deep Learning Approaches for T cell Receptor Design.
    Ribeiro-Filho HV; Jara GE; Guerra JVS; Cheung M; Felbinger NR; Pereira JGC; Pierce BG; Lopes-de-Oliveira PS
    bioRxiv; 2024 Apr; ():. PubMed ID: 38712216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Creation of artificial protein-protein interactions using α-helices as interfaces.
    Yagi S; Akanuma S; Yamagishi A
    Biophys Rev; 2018 Apr; 10(2):411-420. PubMed ID: 29214605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De novo protein design by inversion of the AlphaFold structure prediction network.
    Goverde CA; Wolf B; Khakzad H; Rosset S; Correia BE
    Protein Sci; 2023 Jun; 32(6):e4653. PubMed ID: 37165539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying well-folded
    Peñas-Utrilla D; Marcos E
    Front Mol Biosci; 2022; 9():991380. PubMed ID: 36275629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Harnessing the druggability at orthosteric and allosteric sites of PD-1 for small molecule discovery by an integrated in silico pipeline.
    Mittal L; Tonk RK; Awasthi A; Asthana S
    Comput Biol Chem; 2023 Dec; 107():107965. PubMed ID: 37826990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo design of high-affinity binders of bioactive helical peptides.
    Vázquez Torres S; Leung PJY; Venkatesh P; Lutz ID; Hink F; Huynh HH; Becker J; Yeh AH; Juergens D; Bennett NR; Hoofnagle AN; Huang E; MacCoss MJ; Expòsit M; Lee GR; Bera AK; Kang A; De La Cruz J; Levine PM; Li X; Lamb M; Gerben SR; Murray A; Heine P; Korkmaz EN; Nivala J; Stewart L; Watson JL; Rogers JM; Baker D
    Nature; 2024 Feb; 626(7998):435-442. PubMed ID: 38109936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A New Hybrid Neural Network Deep Learning Method for Protein-Ligand Binding Affinity Prediction and De Novo Drug Design.
    Limbu S; Dakshanamurthy S
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rare, high-affinity mouse anti-PD-1 antibodies that function in checkpoint blockade, discovered using microfluidics and molecular genomics.
    Adler AS; Mizrahi RA; Spindler MJ; Adams MS; Asensio MA; Edgar RC; Leong J; Leong R; Johnson DS
    MAbs; 2017; 9(8):1270-1281. PubMed ID: 28846506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-Guided Discovery of PD-1/PD-L1 Interaction Inhibitors: Peptide Design, Screening, and Optimization via Computation-Aided Phage Display Engineering.
    Tseng TS; Lee CC; Chen PJ; Lin CY; Chen WC; Lee YC; Lin JH; Chen KW; Tsai KC
    J Chem Inf Model; 2024 Mar; 64(5):1615-1627. PubMed ID: 38356220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fast, accurate ranking of engineered proteins by target-binding propensity using structure modeling.
    Ding X; Chen X; Sullivan EE; Shay TF; Gradinaru V
    Mol Ther; 2024 Jun; 32(6):1687-1700. PubMed ID: 38582966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.